Xiaoli Shi

机构：Nanjing Agricultural University, Shanxi Medical University, Shanxi Academy of Medical Sciences, Shanxi Cardiovascular Hospital · ORCID：0000-0001-7641-9762

发表论文 37 篇 · 总被引 951 次 · h-index 15

代表论文

• TGR5 Regulates Macrophage Inflammation in Nonalcoholic Steatohepatitis by Modulating NLRP3 Inflammasome Activation (2021 · Frontiers in Immunology · 被引 178)
• Targeting the Bcl-2 family and P-glycoprotein reverses paclitaxel resistance in human esophageal carcinoma cell line (2017 · Biomedicine & Pharmacotherapy · 被引 38)
• Sodium Butyrate Supplementation Alleviates the Adaptive Response to Inflammation and Modulates Fatty Acid Metabolism in Lipopolysaccharide-Stimulated Bovine Hepatocytes (2018 · Journal of Agricultural and Food Chemistry · 被引 37)
• Luteolin combined with low‐dose paclitaxel synergistically inhibits epithelial–mesenchymal transition and induces cell apoptosis on esophageal carcinoma in vitro and in vivo (2021 · Phytotherapy Research · 被引 28)
• SIRT1 expression regulates the transformation of resistant esophageal cancer cells via the epithelial-mesenchymal transition (2018 · Biomedicine & Pharmacotherapy · 被引 24)
• Development and Validation of a Novel Model to Predict Regional Lymph Node Metastasis in Patients With Hepatocellular Carcinoma (2022 · Frontiers in Oncology · 被引 23)